We are live on ! Find out more
ELEV

Elevation Oncology

Delisted

ELEV was delisted on the 22nd of July, 2025.

Name Holding Trade Value Shares
Change
Change in
Stake
ACM
1
Aisling Capital Management
New York
$5.39M
QUSVM
2
Qiming U.S. Ventures Management
Washington
$4.5M
BI
3
BVF Inc
California
$4.39M
CAM
4
Cormorant Asset Management
Massachusetts
$3.71M
VP
5
venBio Partners
California
$3.55M
TCM
6
Tang Capital Management
California
$2.66M +$1.19M +920,146 +192%
SCM
7
Sio Capital Management
New York
$1.67M +$667K +516,880 +144%
SB
8
Samsara BioCapital
California
$1.58M
Vanguard Group
9
Vanguard Group
Pennsylvania
$866K +$158K +122,473 +37%
Walleye Capital
10
Walleye Capital
New York
$825K +$561K +434,448 New
KCM
11
Kennedy Capital Management
Missouri
$284K
Morgan Stanley
12
Morgan Stanley
New York
$282K +$191K +148,335 +128,987%
Geode Capital Management
13
Geode Capital Management
Massachusetts
$248K +$51.7K +40,037 +44%
Two Sigma Investments
14
Two Sigma Investments
New York
$141K +$95.4K +73,958 New
CC
15
Caxton Corporation
New Jersey
$130K
BCM
16
Bridgeway Capital Management
Texas
$107K -$101K -78,000 -58%
Renaissance Technologies
17
Renaissance Technologies
New York
$98K -$191K -148,400 -74%
AC
18
Annandale Capital
Texas
$95K
State Street
19
State Street
Massachusetts
$80K +$30.5K +23,600 +128%
BlackRock
20
BlackRock
New York
$62.2K -$6.18K -4,791 -13%
BC
21
BIT Capital
Germany
$56K +$38K +29,456 New
VF
22
Virtu Financial
New York
$52K +$35.2K +27,286 New
JP Morgan Chase
23
JP Morgan Chase
New York
$42K +$23.4K +18,107 +427%
Northern Trust
24
Northern Trust
Illinois
$28.5K +$19.3K +14,991 New
Jane Street
25
Jane Street
New York
$19.9K +$13.5K +10,449 New